Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Dimethyl fumarate for treating relapsing multiple sclerosis.
CNS Myelination Requires Cytoplasmic Dynein Function.
Regulatory B Cells and Mechanisms.
Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients.
Internal jugular veins out flow in patients with multiple sclerosis:a catheter venography study.
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
Atypical presentation of multiple sclerosis.
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Lyme disease associated neuroretinitis - Case report.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Pages
« first
‹ previous
…
552
553
554
555
556
557
558
559
560
…
next ›
last »